TransCode Therapeutics (RNAZ) AGM 2025 summary

Opening remarks and agenda

• Meeting called to order with quorum confirmed; inspector of election appointed and sworn in.

• Agenda included voting on a reverse stock split proposal and an adjournment proposal.

Shareholder proposals

• Proposal to authorize a reverse stock split at a ratio between 1-for-10 and 1-for-40, at the board's discretion.

• Proposal to approve adjournment of the meeting if more time was needed for proxy solicitation.

Overview of voting outcomes

• Both the reverse stock split and adjournment proposals were approved by a majority of votes cast.

• Final vote counts to be included in meeting minutes and SEC filings.